应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BOLD Boundless Bio, Inc.
休市中 11-15 16:00:00 EST
3.01
-0.23
-7.10%
盘后
3.01
+0.00
0.00%
16:00 EST
最高
3.30
最低
2.89
成交量
11.21万
今开
3.30
昨收
3.24
日振幅
12.81%
总市值
6,712万
流通市值
4,260万
总股本
2,230万
成交额
34.15万
换手率
0.79%
流通股本
1,415万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Boundless Bio, Inc.盘中异动 早盘急速跳水6.44%报3.34美元
市场透视 · 11-14
Boundless Bio, Inc.盘中异动 早盘急速跳水6.44%报3.34美元
Boundless Bio, Inc.盘中异动 股价大跌5.00%报3.33美元
市场透视 · 11-12
Boundless Bio, Inc.盘中异动 股价大跌5.00%报3.33美元
Boundless Bio, Inc.盘中异动 股价大涨5.87%报3.36美元
市场透视 · 11-08
Boundless Bio, Inc.盘中异动 股价大涨5.87%报3.36美元
Boundless Bio, Inc.盘中异动 股价大涨5.31%报3.08美元
市场透视 · 10-28
Boundless Bio, Inc.盘中异动 股价大涨5.31%报3.08美元
Boundless Bio, Inc.盘中异动 早盘股价大跌5.69%报2.82美元
市场透视 · 10-25
Boundless Bio, Inc.盘中异动 早盘股价大跌5.69%报2.82美元
Boundless Bio, Inc.盘中异动 早盘股价大涨5.46%
市场透视 · 10-11
Boundless Bio, Inc.盘中异动 早盘股价大涨5.46%
Boundless Bio, Inc.盘中异动 早盘急速上涨5.52%报3.06美元
市场透视 · 10-10
Boundless Bio, Inc.盘中异动 早盘急速上涨5.52%报3.06美元
Boundless Bio, Inc.盘中异动 大幅下挫6.34%报3.25美元
市场透视 · 10-01
Boundless Bio, Inc.盘中异动 大幅下挫6.34%报3.25美元
Boundless Bio, Inc.盘中异动 股价大跌5.60%报3.20美元
市场透视 · 09-25
Boundless Bio, Inc.盘中异动 股价大跌5.60%报3.20美元
Boundless Bio, Inc.盘中异动 股价大跌5.14%报3.51美元
市场透视 · 09-24
Boundless Bio, Inc.盘中异动 股价大跌5.14%报3.51美元
Boundless Bio, Inc.盘中异动 早盘股价大跌6.14%报4.13美元
市场透视 · 09-23
Boundless Bio, Inc.盘中异动 早盘股价大跌6.14%报4.13美元
Boundless Bio, Inc.盘中异动 下午盘急速上涨5.04%
市场透视 · 09-20
Boundless Bio, Inc.盘中异动 下午盘急速上涨5.04%
【Liquity V2即将推出:将引入新LQTY质押模块,25%协议收入用于激励流动性】9月11日消息,去中心化借贷协议Liquity即将推出V2版本,引入全新的LQTY质押模块,打破传统投票托管(ve)系统模式。
金色财经 · 09-11
【Liquity V2即将推出:将引入新LQTY质押模块,25%协议收入用于激励流动性】9月11日消息,去中心化借贷协议Liquity即将推出V2版本,引入全新的LQTY质押模块,打破传统投票托管(ve)系统模式。
【Liquity高管:预计将在两个月内推出新稳定币BOLD】金色财经报道,Liquity 高管 Colin Platt 表示,该公司距离发布其新的稳定币 BOLD 还有大约两个月的时间,BOLD 解决了导致 LUSD 在过去一年中急剧下滑的一些缺陷,并且将赋予社区一小部分控制权。
金色财经 · 09-09
【Liquity高管:预计将在两个月内推出新稳定币BOLD】金色财经报道,Liquity 高管 Colin Platt 表示,该公司距离发布其新的稳定币 BOLD 还有大约两个月的时间,BOLD 解决了导致 LUSD 在过去一年中急剧下滑的一些缺陷,并且将赋予社区一小部分控制权。
首个ecDNA公司,上市5个月,现在裁员
生物制药小编 · 08-15
首个ecDNA公司,上市5个月,现在裁员
美国研究综述-Agenus、Guardant Health、Zoetis
Reuters · 08-14
美国研究综述-Agenus、Guardant Health、Zoetis
美国研究综述-阿波罗、黑石、好时
Reuters · 08-13
美国研究综述-阿波罗、黑石、好时
公司概况
公司名称:
Boundless Bio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Boundless Bio, Inc.最初成立于2018年4月10日,原名Pretzel Therapeutics, Inc.,是一家特拉华州公司。2019年7月8日,公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司,致力于开启癌症治疗的新方式,通过靶向染色体外DNA(ecDNA)来解决癌基因扩增肿瘤患者的显著未满足需求,在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司,利用ecDNA生物学提供变革性的治疗方法,改善和延长患有先前难治性癌基因扩增癌的患者的生命。
发行价格:
--
{"stockData":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":3.01,"timestamp":1731704400000,"preClose":3.24,"halted":0,"volume":112075,"hourTrading":{"tag":"盘后","latestPrice":3.01,"preClose":3.01,"latestTime":"16:00 EST","volume":582,"amount":1751.82,"timestamp":1731704402135},"delay":0,"floatShares":14151900,"shares":22298562,"eps":-5.212569,"marketStatus":"休市中","marketStatusCode":7,"change":-0.23,"latestTime":"11-15 16:00:00 EST","open":3.3,"high":3.3,"low":2.885,"amount":341523.222342,"amplitude":0.128086,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.212569,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1711598400000,"adjPreClose":3.24,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.01,"preClose":3.01,"latestTime":"16:00 EST","volume":582,"amount":1751.82,"timestamp":1731704402135},"volumeRatio":2.144368671508851},"requestUrl":"/m/hq/s/BOLD/wiki","defaultTab":"wiki","newsList":[{"id":"2483061383","title":"Boundless Bio, Inc.盘中异动 早盘急速跳水6.44%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483061383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483061383?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:48","pubTimestamp":1731599283,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时48分,Boundless Bio, Inc.股票出现异动,股价大幅下挫6.44%。截至发稿,该股报3.34美元/股,成交量2.3512万股,换手率0.11%,振幅7.28%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2725.16%、229.81%、40.08%,振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药,振幅分别为112.92%、86.36%、73.75%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234803abc1830d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234803abc1830d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2482473737","title":"Boundless Bio, Inc.盘中异动 股价大跌5.00%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482473737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482473737?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:37","pubTimestamp":1731343020,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时37分,Boundless Bio, Inc.股票出现异动,股价大幅跳水5.00%。截至发稿,该股报3.33美元/股,成交量1.6193万股,换手率0.07%,振幅7.43%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为647.39%、482.88%、193.18%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd,振幅分别为123.43%、72.42%、61.39%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003700abb6a21e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003700abb6a21e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2481135741","title":"Boundless Bio, Inc.盘中异动 股价大涨5.87%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481135741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481135741?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:46","pubTimestamp":1730998013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时46分,Boundless Bio, Inc.股票出现异动,股价快速上涨5.87%。截至发稿,该股报3.36美元/股,成交量2.5468万股,换手率0.11%,振幅6.75%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Ensysce Biosciences, Inc.涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为854.21%、351.76%、105.13%,振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.,振幅分别为84.83%、68.89%、57.79%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108004653abaabb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108004653abaabb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2478396481","title":"Boundless Bio, Inc.盘中异动 股价大涨5.31%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478396481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478396481?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:34","pubTimestamp":1730122480,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时34分,Boundless Bio, Inc.股票出现波动,股价快速上涨5.31%。截至发稿,该股报3.08美元/股,成交量1944股,换手率0.01%,振幅0.00%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Revance Therapeutics, Inc.涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为546.36%、48.26%、36.93%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为34.60%、18.35%、15.73%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821344098e3ecf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821344098e3ecf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2478493162","title":"Boundless Bio, Inc.盘中异动 早盘股价大跌5.69%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478493162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478493162?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:27","pubTimestamp":1729866460,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时27分,Boundless Bio, Inc.股票出现异动,股价快速下跌5.69%。截至发稿,该股报2.82美元/股,成交量2.5363万股,换手率0.11%,振幅5.65%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.、Immunitybio, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为729.18%、657.39%、159.62%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.,振幅分别为91.58%、77.79%、69.41%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222741971a259b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222741971a259b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2474801536","title":"Boundless Bio, Inc.盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474801536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474801536?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:10","pubTimestamp":1728659443,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时10分,Boundless Bio, Inc.股票出现波动,股价急速上涨5.46%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Conduit Pharmaceuticals Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃,换手率分别为248.12%、172.77%、24.03%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为170.59%、95.70%、70.00%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123104498e3be90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123104498e3be90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2474474256","title":"Boundless Bio, Inc.盘中异动 早盘急速上涨5.52%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474474256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474474256?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:24","pubTimestamp":1728570287,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时24分,Boundless Bio, Inc.股票出现波动,股价快速上涨5.52%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Seastar Medical Holding Corp C/Wts 28/10/2027 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为257.29%、140.32%、105.64%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 24/02/2025、Genenta Science Spa,振幅分别为66.67%、34.74%、25.48%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010222447ab692aee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010222447ab692aee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2472705193","title":"Boundless Bio, Inc.盘中异动 大幅下挫6.34%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472705193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472705193?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:58","pubTimestamp":1727794686,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时58分,Boundless Bio, Inc.股票出现异动,股价快速跳水6.34%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃,换手率分别为627.05%、554.77%、113.56%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为97.67%、82.42%、64.04%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012258079719db93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012258079719db93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2470126865","title":"Boundless Bio, Inc.盘中异动 股价大跌5.60%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470126865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470126865?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:31","pubTimestamp":1727271116,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时31分,Boundless Bio, Inc.股票出现异动,股价急速下挫5.60%。截至发稿,该股报3.20美元/股,成交量701股,换手率0.00%,振幅0.00%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大,Seelos Therapeutics, Inc.、Elevai Labs, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为181.46%、54.43%、42.71%,振幅较大的相关个股有Notable Labs, Ltd.、Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.,振幅分别为18.95%、17.72%、10.57%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252131569719c97a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252131569719c97a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2470997419","title":"Boundless Bio, Inc.盘中异动 股价大跌5.14%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470997419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470997419?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:30","pubTimestamp":1727191817,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时30分,Boundless Bio, Inc.股票出现波动,股价快速下跌5.14%。截至发稿,该股报3.51美元/股,成交量1.7703万股,换手率0.08%,振幅6.22%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大,Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃,换手率分别为3903.14%、180.77%、125.97%,振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.,振幅分别为101.84%、58.52%、45.08%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423301798e38afa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423301798e38afa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2469171145","title":"Boundless Bio, Inc.盘中异动 早盘股价大跌6.14%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469171145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469171145?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:04","pubTimestamp":1727103870,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时04分,Boundless Bio, Inc.股票出现异动,股价快速下跌6.14%。Boundless Bio, Inc.股票所在的生物技术行业中,整体跌幅为1.05%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为250.74%、46.33%、43.98%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Black Diamond Therapeutics, Inc.,振幅分别为42.83%、42.78%、25.84%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230430ab655fd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230430ab655fd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2468688002","title":"Boundless Bio, Inc.盘中异动 下午盘急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468688002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468688002?lang=zh_cn&edition=full","pubTime":"2024-09-20 01:22","pubTimestamp":1726766552,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日01时22分,Boundless Bio, Inc.股票出现波动,股价快速拉升5.04%。截至发稿,该股报3.65美元/股,成交量2.7961万股,换手率0.13%,振幅4.01%。Boundless Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.72%。其相关个股中,Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Galmed Pharmaceuticals Ltd.涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃,换手率分别为5097.96%、920.95%、210.80%,振幅较大的相关个股有Exicure, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galmed Pharmaceuticals Ltd.,振幅分别为110.91%、88.80%、78.69%。Boundless Bio, Inc.公司简介:Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920012232ab64a988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920012232ab64a988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2466333822","title":"【Liquity V2即将推出:将引入新LQTY质押模块,25%协议收入用于激励流动性】9月11日消息,去中心化借贷协议Liquity即将推出V2版本,引入全新的LQTY质押模块,打破传统投票托管(ve)系统模式。","url":"https://stock-news.laohu8.com/highlight/detail?id=2466333822","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466333822?lang=zh_cn&edition=full","pubTime":"2024-09-11 22:48","pubTimestamp":1726066081,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2466216938","title":"【Liquity高管:预计将在两个月内推出新稳定币BOLD】金色财经报道,Liquity 高管 Colin Platt 表示,该公司距离发布其新的稳定币 BOLD 还有大约两个月的时间,BOLD 解决了导致 LUSD 在过去一年中急剧下滑的一些缺陷,并且将赋予社区一小部分控制权。","url":"https://stock-news.laohu8.com/highlight/detail?id=2466216938","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466216938?lang=zh_cn&edition=full","pubTime":"2024-09-09 19:52","pubTimestamp":1725882760,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["UBmain","LDO.USD.HKCC","TNmain","BOLD","ZTmain","ZNmain","BK4139","ZFmain","ZBmain"],"gpt_icon":0},{"id":"2459633064","title":"首个ecDNA公司,上市5个月,现在裁员","url":"https://stock-news.laohu8.com/highlight/detail?id=2459633064","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459633064?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:21","pubTimestamp":1723684862,"startTime":"0","endTime":"0","summary":"近日,世界首个ecDNA公司Boundless Bio在其递交给SEC的文件中宣布,即将进行适度裁员。这家今年3月才上市的公司,不到五个月就选择了裁员。Boundless Bio就打算开发能够破坏ecDNA形成和功能的新型疗法,理论上阻碍ecDNA或许就能够治疗癌症。除了管线之外,该公司还有相应匹配的ecDNA的检测。这可能和入组标准和排除标准有关,ecDNA是和肿瘤基因扩增相关的,因此这一标准可以体现在患者入组和排除标准里。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150955509599d4ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150955509599d4ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2244417387.USD","BOLD","BK4139","BK4019","LU0187121727.USD","LU0077335932.USD","RNR"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":" 路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Agenus、Guardant Health 和 Zoetis。要闻 * Agenus Inc :B. Riley将目标价从42美元下调至18美元 * Clorox :杰富瑞将目标价从 148 美元上调至 151 美元 * Guardant Health Inc :Raymond James将目标价从28美元上调至36美元 * 星巴克 :Stifel将其评级从 \"持有 \"上调至 \"买入\";将目标价从80美元上调至110美元 * Zoetis Inc :Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDXX","AMCX","EMR","ANNX","BOLD","AGEN","ED","LU","CLX","CTNM","HEI","SLRN","WTRG","ATKR","IBTA","LU0205193047.USD","FTHM","HD","LU2506952410.USD","MO","LU0942090050.USD","CMS","ADVM","EIX","ETR","LU2506952337.HKD","BALL","ALUR","FENC","AWK","ES","FE","AEP","GH","BKH","SKY","FEMY","CNP","D","AIZ","EXC","CPK","LU0149725797.USD","LU2211815571.USD","BHF","DUK","LU1363072403.SGD"],"gpt_icon":1},{"id":"2459926585","title":"美国研究综述-阿波罗、黑石、好时","url":"https://stock-news.laohu8.com/highlight/detail?id=2459926585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459926585?lang=zh_cn&edition=full","pubTime":"2024-08-13 16:45","pubTimestamp":1723538737,"startTime":"0","endTime":"0","summary":" 路透8月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括阿波罗、黑石和好时。要闻 * 阿波罗 :杰富瑞将目标价从 129 美元下调至 114 美元 * Blackstone :杰富瑞将目标价从 138 美元上调至 147 美元 * 好时 :高盛给予卖出评级 * Palomar Holdings Inc :KBW将目标价从96美元上调至113美元 * 沃尔玛 :CFRA将目标价上调3美元至75美元 以下是路透周二报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKAM","AKYA","AMCX","BK4116","APO","BOLD","ALTG","CWEN","AZEK","HSY","GIS","LU2211817866.USD","LU0175139822.USD","BVS","THG","LU1720051017.SGD","GH","DNMR","IE00BKVL7J92.USD","APLS","LU1917777945.USD","CTKB","GETY","LU1244550221.USD","BK4533","ADVM","BX","ROAD","BK4535","ARDT","DE","CEG","ENV","CMBM","CNNE","DYN","AMPX","BK4554","EYPT","ARES","AJG","CAG","CMPX","FTRE","HLT","LU1366333091.USD","ESPR","DUK","COMM","AIG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boundlessbio.com","stockEarnings":[{"period":"1week","weight":-0.14},{"period":"1month","weight":-0.0099},{"period":"3month","weight":-0.0906},{"period":"6month","weight":-0.6887},{"period":"1year","weight":-0.8119},{"period":"ytd","weight":-0.8119}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Boundless Bio, Inc.最初成立于2018年4月10日,原名Pretzel Therapeutics, Inc.,是一家特拉华州公司。2019年7月8日,公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司,致力于开启癌症治疗的新方式,通过靶向染色体外DNA(ecDNA)来解决癌基因扩增肿瘤患者的显著未满足需求,在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司,利用ecDNA生物学提供变革性的治疗方法,改善和延长患有先前难治性癌基因扩增癌的患者的生命。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.045467},{"month":2,"riseRate":0.25,"avgChangeRate":0.036219},{"month":3,"riseRate":0.666667,"avgChangeRate":0.088311},{"month":4,"riseRate":0.333333,"avgChangeRate":0.028717},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032827},{"month":6,"riseRate":1,"avgChangeRate":0.142257},{"month":7,"riseRate":0.666667,"avgChangeRate":0.021175},{"month":8,"riseRate":0.5,"avgChangeRate":-0.031707},{"month":9,"riseRate":0.75,"avgChangeRate":0.116011},{"month":10,"riseRate":0,"avgChangeRate":-0.120737},{"month":11,"riseRate":0.75,"avgChangeRate":0.014772},{"month":12,"riseRate":0.75,"avgChangeRate":0.282026}],"exchange":"NASDAQ","name":"Boundless Bio, Inc.","nameEN":"Boundless Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Boundless Bio, Inc.,BOLD,Boundless Bio, Inc.股票,Boundless Bio, Inc.股票老虎,Boundless Bio, Inc.股票老虎国际,Boundless Bio, Inc.行情,Boundless Bio, Inc.股票行情,Boundless Bio, Inc.股价,Boundless Bio, Inc.股市,Boundless Bio, Inc.股票价格,Boundless Bio, Inc.股票交易,Boundless Bio, Inc.股票购买,Boundless Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}